European Case Law Identifier: | ECLI:EP:BA:1994:T096492.19940823 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 23 August 1994 | ||||||||
Case number: | T 0964/92 | ||||||||
Application number: | 88116669.8 | ||||||||
IPC class: | C07D 319/20 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | 1,4-Benzodioxane derivatives, process for preparing them, pharmacological composition and use | ||||||||
Applicant name: | Eisai Co., Ltd. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.01 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Inventive step (no - obvious alternative) Common general knowledge Identification of the technical problem and the closest state of the art |
||||||||
Catchwords: |
The question as to what extent a chemical structure can be modified without causing major changes in its biological activity is equally relevant to the question as to whether or not it is credible that all members of a certain group of chemical compounds solve a particular technical problem, e. g. whether they can be fairly assumed to be useful in a therapeutical treatment, and to the question of whether or not such an activity can be expected on the basis of the state of the art. If the answer to the former question can only be yes with respect to considerations forming part of the common general knowledge, then the question whether or not the solution of the same technical problem by providing the same group of compounds was obvious must be answered on the basis of the same considerations (No. 2.8. of the reasons). |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t920964eu1.html
Date retrieved: 17 May 2021